Instructor, Medicine, University of Washington School of Medicine
Oncology
Dr. Andrew R. Rezvani, MD
|
|
Give Review
Andrew R. Rezvani works in the field of Oncology. Andrew Rezvani is a published physician as well. He has 14 publications published. The latest was: Long-Term Outcomes of Patients with Persistent Indolent B-cell Malignancies Undergoing Nonmyeloablative Allogeneic Transplantation. Doctor Andrew R. Rezvani, MD is registered with Medicare and accepts Medicare payments.
Publications
- Long-Term Outcomes of Patients with Persistent Indolent B-Cell Malignancies Undergoing Nonmyeloablative Allogeneic Transplantation.
- Impact of donor age on outcome after allogeneic hematopoietic Cell transplantation.
- Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin Lymphoma: indications and outcomes.
- Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic Cell transplantation: pharmacokinetics and clinical outcomes.
- Inducible Costimulator (ICOS) Up-Regulation on Activated T Cells in Chronic Graft-Versus-Host Disease After Dog Leukocyte Antigen-Nonidentical Hematopoietic Cell Trans...
- Prevention of Graft-vs.-host disease.
- Decreased serum albumin as a biomarker for severe Acute graft-vs.-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
- Rituximab resistance.
- Treatment change as a predictor of outcome among patients with classic Chronic graft-versus-host disease.
- Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell Lymphoma: a multicentre experience.
- Separation of Graft-vs.-tumor effects from Graft-vs.-host disease in allogeneic hematopoietic cell transplantation.
- Using allogeneic stem cell/T-cell Grafts to cure hematologic malignancies.
- Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's Lymphoma.
Schools
Temple University
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Washington -
Duke University Hospital
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1609983485 | |
| NPPES Provider LastName | REZVANI | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 981956340 | |
| NPPES Provider State | WA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 13.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609983485 |
| Last Name Of The Provider | REZVANI |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
|
Dr. Sujata Rao, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joe Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin A. Cheever, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jorge Ramos, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Johnnie J. Orozco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Montgomery, MD |
|
|
Dr. Bernardo H. Goulart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seth M. Pollack, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cassian K. Yee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacey A. Shiovitz, MD |
|
|
Dr. Howard L. West, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sunil R. Hingorani, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Henry O. Otero, MD |